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1. Introduction
Seizures are a very common problem that accompany the humanity since its origin, and epi-
leptic seizure (ES) was considered as a sacred disease for thousands of years, while for the 
past hundred year, a real knowledge of its etiopathogenetic mechanism is better known.
In one of the chapters of this book, an overview of genetic testing modalities and work-
flows taking into account genetic architecture of epilepsies is given, and practical aspects of 
genetic testing in epilepsies, including advantages/limitations and clinical utility of tests, are 
discussed.
Other chapters of this book aim to present in synthesized form the genetic, immunological, 
and environmental factors’ role in the autoimmunity to epilepsy, as well as the therapeutic 
approach that has been used to control seizures, mainly where there is a suspected anti-neu-
ronal-antibody circulation. A review of the work achieved during the last years in patients 
with this condition provides information and experience in the diagnosis and treatment of 
this epilepsy type. In this chapter, the authors conducted a systematic search of PUBMED, for 
articles published between 1990 and December 2016 using the search terms “autoimmune and 
epilepsy,” “autoantibodies and epilepsy,” NMDA and epilepsy, AMPA and epilepsy, and 
GAD and epilepsy. The list of identified articles was complemented by additional searches 
for relevant articles in the reference section of the publications captured by the initial search.
In another chapter, the authors estimated the prevalence of ischemic stroke (IS) in epileptic 
patients presenting subarachnoid neurocysticercosis (SNCC) and IS frequency among HIV-
positive patients in three NCC subgroups. Finally, to determine if the odds of ischemic stroke 
are elevated in SNCC patients compared to patients with intraparenchymal NCC (INCC). 
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
They determined whether the risk for IS is elevated in HIV-seropositive patients presenting 
with SNCC or intraparenchymal NCC (INCC) and evaluated if and when the potential inter-
action varies by location of NCC in the brain. Eligible epileptic patient’s seropositive status 
was recorded, and cross associations for the independent variables (NCC status and HIV 
status) and outcome variables (IS event) were performed.
The authors compared the INCC SNCC group to the reference group; the odds of IS in 
PLWNCC were 2.0 and 2.6 times greater patients with SNCC and INCC, respectively. The 
frequency of IS was greater in HIV-positive patients in all three groups, but the risk was espe-
cially pronounced when seropositive epileptic patients were both NCC groups when com-
pared with the reference group, subarachnoid space that risk increased tree times more.
In the chapter entitled “Self-Reporting Technologies for Supporting Epilepsy Treatment,” 
the authors conducted interviews, a literature review, an expert panel, and online surveys 
to assess the availability and quality of patient-reported data that is useful but reported as 
being unavailable, difficult for patients to collect, or unreliable during epilepsy diagnosis 
and treatment, respectively. Their results highlight important yet underexplored data col-
lection and design opportunities for supporting the diagnosis, treatment, and self-manage-
ment of epilepsy and expose notable gaps between clinical data needs and current patient 
practices.
The chapter entitled “Psychogenic Non-epileptic Seizures in Patients Living with Neuro-
cysticercosis” analyzes the results of one study about patients presenting epileptic seizures 
and pseudo-seizures (psychogenic non-epileptic seizures [PNES]) and living with NCC done 
in rural South Africa. NCC is the leading cause of secondary epilepsy in developing countries 
where PNES is also a frequent problem, then to distinguish real seizures from PNES is a chal-
lenge. Therefore, the author reviewed the recent medical literature and compared it with their 
results and highlighted how to differentiated epileptic seizures from PNES.
2. Background history
The main clinical manifestation of NCC is ES; then the first human being presenting NCC 
also had ES. Probably the first human being infected by Taenia solium was the Homo ergaster 
[1, 2]. Therefore, the history of epileptic seizures began at the Lower Pleistocene (between 1.51 
and 1.56 million years ago) when H. ergaster lived. Tapeworms that plague humanity originated 
in carnivores such as lions, hyenas, or African dogs and jumped to humans after they began eating 
their prey animals on the African savannah [2]. Modern humans share the same differences as 
H. ergaster with Asian H. erectus, leading the possibility that H. ergaster is the ancestor of later 
Homo population [2, 3]. In our opinion the first epileptic patient was a H. ergaster. Because 
the humans are the most important element in the T. solium transmission, we assumed that 
H. ergaster was the first transmitter of the tapeworms to the savage animals and from the 
infected animals, he got the infection with T. solium through their eggs and proglottids present 
in the contaminated water and/or food.
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2.1. Ancient times
Seizure disorders, and the mysteries surrounding them, have been discussed for nearly 
4000 years starting with Assyria, Akkadia, and Babylonia. Babylonians and Sumerians 
believed that it had supernatural causes like other diseases.
Many years after the H. ergaster disappeared, the habitants of earth continue being infected by 
T. solium suffered from NCC and, obviously, presenting ES. The earliest report of seizures is 
available in the Sakikku, a Babylonian cuneiform medical diagnostic text from 1067 to 1046 BC 
where the current description of epilepsy is named miqtu (“the falling disease”) [4].
According to Eadie and Bladin [5] “with the probable exceptions of the absence and myo-
clonic seizures of today’s generalized epilepsy, the Sakikku mentions probable examples of 
all the major contemporary classificational types of epileptic seizures. The fact the ancient and 
unknown author or authors of the Sakikku saw fit to bring such phenomena together in the 
account indicates recognition of the fundamental kinship of these phenomena. The ascribing 
of them all to miqtu, suggest that they were all taken to be various expressions of the same 
underlying disorder. Moreover, the authors (s) also distinguished between miqtu and a pos-
sible pseudo-seizure.”
Historically, people with epilepsy were considered to be demonically possessed, to be witches 
or even insane [6]. The history of epilepsy and its treatment in the western world dates back at least 4 
millennia to the ancient civilization of the Middle East. Past and present treatments have been empiri-
cal, usually reflecting the prevailing views of epilepsy, be they medical, theological, or superstitious. 
Ancient physicians relied on clinical observation to distinguish between epileptic syndromes and infer 
their cause [7]. In this period other peoples also worked on the field of epileptic seizures such 
as Atreya the father of the Indian Medicine who wrote the Charaka Samhita (sixth century BC) 
[8]. The Huang Di Nei Ching was written by a group of Chinese physicians between circa 770 
and 221BC; they wrote on epilepsy and delivered a description about an epileptic seizure 
(epilepsy mania) [9].
In 400 BC Hippocrates, the father of medicine, offered another point of view on epilepsy that 
it was just another natural disease and could be treated through natural methods. On the 
Sacred Disease was regarded as the oldest surviving medical account of epilepsy, where he 
argued that the epileptic seizures were not sacred in its origins [5]. He supported the use of 
medicine and control of the diet in order to cure this disease based on his theories of medical 
methodology. While his methods were hardly scientific, he was the first to consider epilepsy 
to be a natural disorder and would be the only one to do so for centuries. After the Greeks the 
Romans took a view similar to that of the Babylonians as to the nature of epilepsy [6].
Magiorkinis et al. [10] said that “The first formal description of epilepsy as a disease should 
be attributed to the father of medicine, Hippocrates of Kos, in his classic treatise On the sacred 
disease (Πεとか ιεとおな νούσου). In this book, Hippocrates disputes the divine origin of 
epilepsy by saying: “This disease is in my opinion no more divine than any other; it has the 
same nature as other diseases, and the cause that gives rise to individual diseases. It is also 
curable, no less than other illnesses.”
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After Hippocrates, the experience on ES in Alexandrian, Roman, Middle East, and Asian 
medicine did not reach higher progress, but we should highlight the work done by Diocles 
of Carystus, Praxagoras of Cos, Pedanius Dioscorides, and Aurelius Cornelius Celsus (circa 
30AD) who wrote “Epileptic fits are not difficult to bring to an end, when they have com-
menced before puberty, and whenever the sensation of the coming fit begins in some one part 
of the body. It is best for it to begin from the hands or feet, next from the flanks, worst of all from 
the head” [5]. Aretaeus the Cappadocian was the first to describe visual, olfactory, and audi-
tory auras (second century AD). Aelius (Claudius) Galenus (131–201AD) gave a definition of 
epilepsy: Yet if there is not only convulsion of the whole body, but also interruption of the leading func-
tions, then this is called “epilepsy.” Caelius Aurelianus differentiated two types of ES: deep sleep 
from convulsive (fifth century). Paul of Aegina, the last of Byzantine writers in the late sixth or 
early seventh century, also delivered a definition of ES as paraphrases of those of Galen did, but 
he recognized that seizures in eclampsia proceed from the uterus [5]. Nevertheless, to consider 
the Ancient Chinese Medicine among those great delivers of knowledge is mandatory, and the 
classification of ES in the Zhu Bing Yuan Hou Lun Theu in five types was a great advance [9].
2.2. Medieval times
From our historical review on NCC, we know that mysticism and dogmatism continue influ-
ence all scientific fields including medicine, and many diseases were considered as a conse-
quence of demonic possession; then patients presenting ES were managed as warlocks and 
witches. Several physicians wrote about ES in this period worldwide, and almost all kept the 
same point of view from ancient Great and Romans. The most famous medieval Islamic writ-
ers were Abu Bakr Muhammad Ibn Zakariya al-Razi (85–925), known as Rhazes, and Abu Ali 
al-Husayn ibn Abd Allah ibn Sina (980AD) from Persia, known in the west as Avicenna [11]. 
However in this period, there were other writers with some different criteria about ES that 
should be mentioned: Arnold of Villanova (circa 1234–1311) who defined ES as an occlusion 
of the chief ventricle of the brain [12]. In 1305, Bernard of Gordon adverted to the possibility 
of the existence of simple partial seizures [5, 13]. In 1314, John of Gaddesden (circa 1280–1361) 
wrote about epilepsy in his Rosa medicinae considering that ES without convulsion is possible 
and proposed three forms of epilepsy—minor, medium, and major—assigning the synonyms 
true, truer, and truest. Minor epilepsy is attributed to the obstruction of arteries, medium 
epilepsy to the obstruction of the nerves, and major to an obstruction of the ventricles of the 
brain [14]. However, Antonius Guainerius (died circa 1450) considered that the presence of 
convulsion and foam at the mouth must be part of the clinical feature of ES [15]. According 
to Singer [16] Antonio Benivieni (1443–1502) wrote: “Though the disease called epilepsy is 
among the best known of diseases, yet many are unacquainted with it in the form of which I 
saw it recently in a young Aretine girl. When attacked she did exhibit the usual symptom of 
falling down, nor did she foam at the mouth, but she would just stand still, moving her head 
and neck from side to side as if trying to see something, yet dumb, deaf, and insensible. On 
coming to herself and being asked what she had been doing she did not know in the least.”
Beyerstein [17] suggests that the curious behavior of the possessed people described in the 
classic Malleus Maleficarum (published in Germany in 1487) is likely symptoms of epilepsy 
or Tourette’ syndrome. At the age 13, Joan of Arc experienced moments of ecstasy with light, 
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heard voices of saints, and claimed to see visions with angels, all probably symptoms of epi-
leptic seizure [18].
The first acknowledgement of St. Valentine being a patron saint for people with epilepsy is 
printed in The Nuremberg Chronicle, an illustrated book printed in 1493. St. Valentine was 
known for healing people with epilepsy around Europe including southern Germany, eastern 
Switzerland, Austria, and northern Italy [19].
2.3. Brief history of ES during the renaissance and the enlightenment
In the XIV to XVII centuries (European Renaissance), the Sciences is realized from the Catholic 
Church’s chains, and as a consequences of that, the number of writers with new criteria about 
ES increased remarkably, and also theories regarding the mechanism that causes the epileptic 
fits as well as new classifications of the disease came forth [10]. There were some peoples try-
ing to differentiate epilepsy and demonism.
In 1549, some aspects on ES were written in the first book delivered “about neurology” 
(Pratensis: De Cerebri Morbis) according to Prestonk where the author adopted Galen’s subdi-
vision of epilepsy into three types [20].
By the end of the sixteenth century, Martinus Rulandus (1532–1602) delivered a booklet about 
now known as benign Rolandic epilepsy.
In the seventeenth century, Thomas Willis goes in front of the scientific revolution, and apart 
from his description about anatomy of the blood supply to the brain among other aspects, 
he wrote about ES describing the a typical tonic–clonic seizure as the characteristic epileptic 
convulsive phenomenon: “…The Epileptick fit or assault seems to be the only a universal and 
more cruel Covulsion…” [5]. Paracelsus (1493–1541 AD) dealt with epilepsy. He agrees that 
epilepsy may originate from the brain or the liver, the heart, the intestines, and the limbs but 
he also suspected that epilepsy of a sick priest derived from the presence of brain cyst [2]. 
Paracelsus views about the human nature and the construction of the human body from mer-
cury, sulfur, and salt which led him to a different model for the causes of epilepsy. Ioannes 
Marcus Marci (1595–1667 AD), a Bohemian physician and scientist, broadened the definition 
of epilepsy “to any affection of the body where the victims are disordered in their minds, 
while the members [of the body], be it all, or some, or only one, are moved against their will” 
[10]. John Locke (1632–1704) worked on hysteria and epilepsy.
From the eighteenth century, we should highlight the work done by Herman Boerhaave 
(1669–1738), George Cheyne (1671–1743), and William Cullen (1710–1790) who wrote about 
spasmodic affections without fever together with tetanus and chorea or St. Vitus dance [5]. 
Samuel Tissot a Swiss physician (1728–1797) defined epilepsy as a convulsive illness in which 
every attack interferes with the senses and the understanding and is accompanied by convul-
sive movements of various degrees of severity involving many parts of the body [5].
Pedro de Horta a Mexican physician wrote the first book on epilepsy in the New World (1754) 
published in Madrid. The book contained a discussion of the distinctions to be drawn between 
the different medical disorders embraced by the conditions known locally as “Telele” and 
“Tembeleque” [21]. William Heberden, an English physician (1710–1801), included complex 
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partial seizures (which did not become secondarily generalized) and absence seizures in his 
concept of epilepsy.
2.4. Brief history of ES during the eighteenth and nineteenth centuries
Herman Boerhaave (1668–1738) provided a rather strict definition of epilepsy: “Epilepsy is 
the sudden abolishment of all vital functions with accompanying increase of mobility and 
convulsions in all body muscles,” whereas he adopts the Galenic classification of epilepsy [10].
The Dutch-Austrian Gerard van Swieten (1700–1772) wrote a chapter on epilepsy in which he 
described extensively the clinical characteristics of various forms of the disease and discusses 
epilepsy in comparison with apoplexy and hysteria [22]. By law, at that time peoples present-
ing ES (in Sweden) is prohibited to get married (1757).
The Swiss physician Simon August André David Tissot (1728–1787) published in 1770 the 
first major treatise on epilepsy that is considered to be a milestone in the scientific research 
on epilepsy. At the same time, he refused the theory of the influence of the moon on epileptic 
seizures and accepted the hereditary forms of epilepsy. The Italian naturalist Felice Gaspar 
Ferdinand Fontana (1730–1803), in a series of experiments on stimulation of the cerebral 
cortex with electricity, demonstrated that convulsions could be produced by pressure on 
the brain, but not by irritation of the dura, as commonly believed [23, 24]. Thomas Beddoes 
(1760–1808) described accurately the premonitory symptoms developing before the onset 
of an attack. Sir Charles Locock introduced the first generation of antiepileptic drug (AED), 
bromides (in 1850); since then it was the only available medication for treatment of ES for the 
next 50 years [19]. In November 30, 1893, the Ohio Hospital for patients presenting ES was 
opened.
Connecticut becomes the first American state to prohibit marriage for people with epilepsy 
(1895). House Bill 681 denied the rite of marriage, or to live together unmarried, to individu-
als 45 years old or younger who either had epilepsy or were a pauper, imbecile, or feeble-
minded. Minimum prison sentence would be 3 years. Many states would follow with similar 
rules. This bill was repealed in 1953 with the passage of Public Act 254 [19].
The nineteenth century was the “golden era” of French medicine, and the English school of 
physicians also made a great contribution to the development of knowledge about ES. Marie 
Jean Pierre Flourens (1794–1867) established the basic rules regarding the irritability and sensi-
bility of the central nervous system. The French psychiatrist Jean-Étienne Dominique Esquirol 
French psychiatrist (1772–1840) worked on epilepsy and insanity and identified severe from 
light epileptic seizures (grand mal and petit mal). Based on a large amount of clinical data, 
postmortem reports, and his personal experience, Antoine Baron de Portal (1742–1832) con-
cluded that anatomical dissection did not reveal any lesions either in the brain or other parts 
of the body from patients affected by ES.
From the English school of physicians, numerous writers performed a great contribution to 
the better knowledge of ES, and the list of most famous writers is as follows: (1) James Cowles 
Prichard (1786–1848), Richard Bright (1789–1858), Marshall Hall (1790–1857), Robert Bentley 
Todd (1809–1860), Astley Cooper (1768–1841), John Russell Reynolds (1828–1896), and William 
Richard Gowers (1845–1915) [5].
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In the late 1800, and the beginning of 1900, many American states had colonies for patients 
presenting ES. The first colony was created in 1896 at the Shaker colony, Sonyea, New York 
(Craig Colony). Some colonies had facilities for education or vocational training to epileptic 
patients, while other had not those facilities, and patients remained in disadvantage condi-
tions dealing with isolation, side effects, and poor prognosis [25].
In this period, some German and Dutch physicians reached high levels of development in 
research on ES. Karl Friedrich Burdach (1776–1847) made a remarkable job on anatomical 
abnormalities observed in the brain leading to ES. Friedrich Gustav Jakob Henle (1809–1895), 
writing in 1853, noted that epileptic convulsions were due to increase or decrease of blood 
flow in the hemispheres, and Wilhelm Griesinger (1817–1868), in 1868, employed for the first 
time the term “psychomotor symptoms” in epileptoid conditions [10].
2.5. Brief history of John Hughlings Jackson
Currently, the general community of epileptologists countrywide agrees that John Hughlings 
Jackson (1835–1911) is the father of modern epileptology. He was a very active researcher 
from 1861 to 1870, and almost all of his results have been confirmed by other authors. Based 
on his knowledge on anatomo-pathology, he studied patients with ES. His first publication 
from hospital records and review of the medical literature was made in 1861; 2 years later he 
reported his observation on focal seizures mainly in syphilitic patients and confirmed lesion 
on the brain contralateral to the focal ES. Jackson believed that loss of consciousness was 
secondary to disorder of the very highest level of the cerebral hemisphere and the seizures 
started at the lower levels and then spread to higher ones through interconnecting fibers as 
well as to neighboring cells of the same level. Jackson said: “I do not use the term cortical 
epilepsy because both epileptic and epileptiform seizures are, to my thinking, cortical fits… I 
formerly used the term epilepsy generically for all excessive discharges of the cortex and their 
consequences…” He mentions, writing in 1876, a number of expressions used by patients to 
describe those symptoms of the so-called ‘intellectual aura’, some of which resemble states 
known in modern psychiatry and neurology as ‘déjà vu” [10].
2.6. Twentieth century
In 1903, Herman Bernhard Lundborg (1868–1943) published the first description of progres-
sive myoclonic epilepsy [26].
In 1904, William P. Spratling described his job done at Craig Colony for years as the medical 
superintendent and named him as epileptologist because his services were rendered to epi-
leptics. Today he is considered the first epileptologist in history [10].
Patients with seizures have been denied many rights throughout the ages including education 
and work training. In 1907, legislation denying immigrants with epilepsy (as well as tubercu-
losis and physical disabilities) was passed.
In 1906, Santiago Ramón y Cajal (1852–1934) from Spain received the Novel Prize of Medicine 
as a reward of his efforts [27]. He made remarkable advances in the field of the microscopic 
structure of the central nervous system and described the histological structure of the neuron 
cell and its synapses.
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In March 1907, Indiana was the first state to officially pass a eugenics law regarding to steril-
ization of individuals, including idiots and imbeciles, in state custody. Epileptic patients were 
not officially included in that statement, but in the early 1900s, terms such as idiots, imbeciles, 
and feeble-minded were used interchangeably when referring to people with ES. Many other 
states did the same and included people with ES as well. This law influenced Nazi eugenics 
during the Holocaust [19].
In September 1909, the ILAE held its first meeting and members from Algeria, the USA, 
and eight European countries attended. Ketogenic diet was used for the first time in the 
treatment of epilepsy in 1911 by the French physicians Guelpa and Marie. In 1912, during 
experimental-induced seizures, electric changes in the brain were noticed by Kaufmann, 
and at the same time, Alfred Hauptmann (1881–1948) synthesized phenobarbital, one of the 
first AED [28], whereas Walter Dandy (1886–1946) described in 1918 and 1919 pneumoven-
triculography and pneumoencephalography [10]. Years later, these radiographic tests were 
of great value in the management of peoples with ES. Everybody knows that people with 
ES are denied the right to serve their country during the WW I (1914–1918) and WW II 
(1939–1945).
In 1929, Hans Berger (1873–1941), a psychiatrist, developed the human electroencepha-
lograph (EEG) in Germany. In 1932, Hans Berger informed about patients presenting 
tonic–clonic ES and an associated change on EEG in the postictal period (slow waves) and 
described the typical 3/s rhythmic spike-slow waves in patients with minor seizures. Its 
important application from the 1930s onward was in the field of epilepsy. The EEG also 
helped to find the origin of the ES, to differentiate different types of ES, and shows signals of 
brain damaged due to ES and expanded the possibilities of neurosurgical treatments, which 
became much more widely available from the 1950s onward in London, Montreal, and Paris 
[29]. The job on epileptic EEG done by Berger was completed by Frederic Andrews Gibbs 
(1903–1992) and Erna Gibbs (1904–1987) who in collaboration with William G. Lennox 
established the correlation between EEG findings and epileptic convulsions [30, 31]. Around 
the same time, the main progress in the history of ES is related to the development and 
introduction of new AED for a better management of epileptics. During the same period, 
H. Houston Merritt (1902–1979) and Tracy Putnam (1894–1975) discovered phenytoin and 
its effect on the control of epileptic seizures [32–35]. Phenytoin became the first-line AED for 
the control of partial and generalized tonic–clonic seizures and status epilepticus. In 1946, 
Richards and Everett added trimethadione to the list of AEDs mainly for the treatment of 
absence seizures [36].
During the 1950s, new drugs came up such as carbamazepine in 1953 [37], primidone in 1954, 
ethosuximide in 1958 by Vossen [38], sodium valproate in 1963 by Meunier et al. [39], and 
sultiame. Buchtal and Svensmark were the first ones in 1960 to measure the levels of the anti-
epileptic drugs in the blood [40]. In 1967, valproate came up as a new promising antiepileptic 
drug. Valproate was initially synthesized in 1881 by Beverly Burton in the USA and was initially 
employed as an organic solvent [41]. Newer AED such as vigabatrin (1989), lamotrigine (1990), 
oxcarbazepine (1990), gabapentin (1993), felbamate (1993), topiramate (1995), tiagabine (1998), 
zonisamide (1989 in Japan and 2000 in the USA), levetiracetam (2000), stiripentol (2002), pre-
gabalin (2004), rufinamide (2004), lacosamide (2008), eslicarbazepine (2009), and perampanel 
(2012) were included in the list of medicines to be prescribed [42]. The research on  antiepileptic 
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drugs is an active field, and many drugs are currently under development in clinical trials 
including eslicarbazepine acetate, brivaracetam, and retigabine [42].
One special space in this chapter should be dedicated to the memory of Henri Jean Pascal Gastaut 
(1915–1995) (Figure 1). He was an important and influential figure in the field of EEG whose work 
was intensified during the 1950s. He also worked with William Gray Walter (1910–1977) in Bristol 
learning the basics of EEG and discovered photic stimulation as an EEG seizure activator [42].
Gastaut also worked with Wilder Penfield (1891–1976) and Herbert Jasper (1906–1999) and 
investigated the role of thalamic reticular structures in the genesis of metrazol-induced gen-
eralized paroxysmal EEG discharges and developed the concept of centrencephalic seizures 
in 1949 [43]. Beyond any doubt Gastaut was one of the greatest European researchers in epi-
leptology from our time.
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